Skip to main content
. 2019 Oct 21;102(1):78–89. doi: 10.4269/ajtmh.19-0436

Table 4.

Treatments and duration

Treatment (range) Number (%) Median duration of all treatments in years (range)
Albendazole* 30/34 (88.2) 0.55 (0.05–4.7)
Praziquantel* 20/34 (61.8) 0.96 (0.01–4.3)
Combined* 20/34 (61.8) NA
Corticosteroids* 30/34 (88.2) 1.09 (0.02–5.0)
Methotrexate 17/34 (50.0) 1.37 (0.08–7.92)
Etanercept* 11/34 (34.2) 0.81 (0.11–1.91)
Anakinra 1/30 (0.03) 1.61

NA = not applicable.

* Three persons with calcified subarachnoid did not receive treatment and one person (who received aborted inadequate treatment cysticidal and etanercept) was excluded.